Intermountain’s Blood and Marrow Transplant and Acute Hematology Malignancy Program treats advanced and complicated blood and marrow cancers. These cancers include acute leukemia and aggressive lymphomas as well as myeloma, myelodysplastic syndrome (pre-leukemia), and certain solid tumors (abnormal tissue masses which may or may not be cancerous).

Our cutting-edge BMT treatment options include pioneering half-match (haploidentical) stem cell transplant technology. With half-match technology, a transplant donor can be a family member (such as a child, parent, cousin, niece, or nephew). Historically, a successful transplant required a perfectly matched donor, typically a sibling.

You and your transplant physician will decide which type of transplant is the best treatment option for you.

 
Only accepts physician referrals.